logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

NAI Life Science & Technology - www.nai500.com

Life Science & Technology Weekly 153 – Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer

Jul 26, 2018

Life Science, Technology

Sunniva Inc (CSE:SNN) Cannabis

Sunniva Inc. Unaware of Any Material Change in the Company’s Operations

Jul 26, 2018

Life Science, Technology

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Life Sciences Inc. (TSXV:RP) has Established a Beachhead to China’s Vast Cosmetics and Healthcare Markets – Our Talk with Lee Buckler, President and CEO, on How he was Able to Make this Happen

Jul 26, 2018

Life Science, Technology

GlaxoSmithKline strikes $300 million deal with 23andMe for genetics-driven drug research

Jul 25, 2018

Life Science

Biogen and Eisai say Alzheimer’s treatment slowed disease progression, backing amyloid theory

Jul 25, 2018

Life Science

Terumo Pays $130 Million to Acquire Essen, a Beijing Stent Company

Jul 25, 2018

Life Science

Hillhouse Capital Leads $230M Series B Preferred Stock Financing In US Biopharmaceutical Firm Gossamer Bio

Jul 24, 2018

Life Science

Pfizer Plans $465 Million Project in Michigan, Part of its $5 Billion Manufacturing Plan

Jul 24, 2018

Life Science

Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer

Jul 24, 2018

Life Science

WebMD and Tencent Partner to Deliver Health Information in China

Jul 24, 2018

Life Science

Sanofi Ventures Leads $17 Million Financing of Click Therapeutics

Jul 24, 2018

Life Science

CICC’s Subsidiary Leads $103M Series B In Tumor Radiotherapy Start-up Allcure Medical

Jul 23, 2018

Life Science

Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China

Jul 23, 2018

Life Science

Namaste-Technologies-Inc.-TSXV-N

Namaste Announces Submission of its Application to List on the NASDAQ

Jul 23, 2018

Life Science

Namaste-Technologies-Inc.-TSXV-N

Namaste Announces Quarterly Sales of $4.1M Representing 32% Quarter-Over-Quarter Growth

Jul 23, 2018

Life Science

BeiGene Shows Off Strong Results from Checkpoint Inhibitor While Eying Potential Approval for BTK Inhibitor

Jul 23, 2018

Life Science

Long Hill Capital Closes $265 Million Second Fund for China Health Investments,長嶺資本完成中國醫療保健領域投資的第二支基金募集

Long Hill Capital Closes $265 Million Second Fund for China Health Investments

Jul 23, 2018

Life Science

Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a Year

Jul 20, 2018

Life Science

  • ‹‹ Previous
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada